Indian Pharmaceutical Alliance (IPA) - the lobby group that represents large Indian drug makers, said no discussion took place with Prime Minister Narendra Modi on the alleged bribes given by pharma companies to doctors, as was reported by media outlets.
"The Prime Minister had convened a meeting with the healthcare industry on January 1, 2020, to discuss the future roadmap for growth of the healthcare industry," IPA said in a statement.
"The focus of discussion was on: Research and Development, building innovation ecosystem, improve access to high quality medicine and strengthen global competitiveness of the industry. India is rightly described as the pharmacy of the world with 20 percent volume share of the global market. The purpose was to take the industry to the next level, and leverage opportunities going forward in pharma sector, besides discussing growth opportunities in Medtech and hospital sector," it added.
IPA said the meeting was attended by Satish Reddy of Dr Reddy's, Ajay Piramal (Piramal Group), Pankaj Patel (Cadila Healthcare), Dilip Shanghvi (Sun Pharma), Habil Khorakiwala (Wockhardt), Rajiv Modi, (Cadila Pharma), Sudhir Mehta (Torrent Pharma), Pavan Choudhary (Medical Technology Association of India) and Shobana Kamineni (Apollo Hospitals).